These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 69058)

  • 21. [Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions].
    Gaillat J; Zmirou D; Mallaret MR; Rouhan D; Bru JP; Stahl JP; Delormas P; Micoud M
    Rev Epidemiol Sante Publique; 1985; 33(6):437-44. PubMed ID: 3914014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention.
    Austrian R
    Rev Infect Dis; 1981; 3 Suppl():S1-17. PubMed ID: 7025155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 23-valent pneumococcal vaccine failure in a patient who developed pneumonia: a case report.
    Tafuri S; Martinelli D; Grimaldi A; Lopatriello A; Giorgio V; Prato R
    New Microbiol; 2011 Oct; 34(4):417-20. PubMed ID: 22143817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatal pneumococcal infection: another plea for the pneumococcal vaccine.
    Brandstetter RD; Kaplowitz I; Pugliese A; Andresen A; Phillips E
    N Y State J Med; 1991 Jan; 91(1):36. PubMed ID: 1994308
    [No Abstract]   [Full Text] [Related]  

  • 25. Pneumococcal polysaccharide vaccine prevents death from pneumonia in Papua New Guinean children.
    Lehmann D
    P N G Med J; 1986 Dec; 29(4):281-3. PubMed ID: 3548149
    [No Abstract]   [Full Text] [Related]  

  • 26. Pneumococcal disease and its prevention with polyvalent pneumococcal polysaccharide vaccines--a review.
    Douglas RM; Riley ID
    Aust N Z J Med; 1979 Jun; 9(3):327-38. PubMed ID: 37823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A radioimmunoassay for antibody to pneumococcal polysaccharides.
    Latif AA; Webster AD
    J Immunol Methods; 1982; 49(1):83-8. PubMed ID: 7061872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of pneumococcal polysaccharide vaccine on nonbacteremic pneumococcal pneumonia.
    Weiser JN; Austrian R
    Clin Infect Dis; 2007 Apr; 44(8):1139-40; author reply 1140-1. PubMed ID: 17366469
    [No Abstract]   [Full Text] [Related]  

  • 29. Pneumococcal vaccine: time for another controlled trial.
    Shann F
    Lancet; 1998 May; 351(9116):1600-1. PubMed ID: 9620711
    [No Abstract]   [Full Text] [Related]  

  • 30. When to use the new pneumococcal vaccine.
    Drug Ther Bull; 1990 Apr; 28(8):31-2. PubMed ID: 2131247
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunoprophylaxis of pneumococcal pneumonia.
    Mufson MA; Belshe RB
    W V Med J; 1979 Dec; 75(12):357-9. PubMed ID: 42222
    [No Abstract]   [Full Text] [Related]  

  • 32. Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study.
    Suzuki M; Dhoubhadel BG; Ishifuji T; Yasunami M; Yaegashi M; Asoh N; Ishida M; Hamaguchi S; Aoshima M; Ariyoshi K; Morimoto K;
    Lancet Infect Dis; 2017 Mar; 17(3):313-321. PubMed ID: 28126327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain.
    Caro-Aguilar I; Indrawati L; Kaufhold RM; Gaunt C; Zhang Y; Nawrocki DK; Giovarelli C; Winters MA; Smith WJ; Heinrichs J; Skinner JM
    Vaccine; 2017 Feb; 35(6):865-872. PubMed ID: 28087148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of pneumococcal pneumonia.
    Woodhead M; Macfarlane JT
    Lancet; 1983 May; 1(8332):1044. PubMed ID: 6133080
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pneumococcal pneumonia: epidemiology, therapy, immunoprophylaxis].
    Gartmann J
    Schweiz Med Wochenschr; 1980 Aug; 110(35):1258-65. PubMed ID: 6903401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis.
    Xu Q; Surendran N; Verhoeven D; Klapa J; Ochs M; Pichichero ME
    Vaccine; 2015 Feb; 33(8):993-1000. PubMed ID: 25597944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vaccination against pneumococci].
    Wiedermann G
    Wien Med Wochenschr; 1982 Oct; 132(20):479-84. PubMed ID: 7157810
    [No Abstract]   [Full Text] [Related]  

  • 38. Pneumonia vaccine trials at Tari.
    Riley ID
    P N G Med J; 2002; 45(1-2):44-50. PubMed ID: 14658827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infection control series: IV. Pneumococcal vaccine in the prevention of pneumonia: establishing an immunization program for patients in hospital.
    Mufson MA
    W V Med J; 1981 May; 77(5):111-3. PubMed ID: 6243028
    [No Abstract]   [Full Text] [Related]  

  • 40. Pneumococcal vaccine: clinical efficacy and effectiveness.
    Schwartz JS
    Ann Intern Med; 1982 Feb; 96(2):208-20. PubMed ID: 6800290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.